Patients should contact their GP or prescribing clinician if they experience: Severe or persistent cramps that do not respond to simple measures or significantly impact daily activities and sleep quality Frequent cramping occurring multiple times daily or nightly Associated symptoms such as muscle weakness, numbness, tingling, or changes in sensation, which may indicate neurological involvement Visible muscle changes including swelling, redness, tenderness, or asymmetry between legs Signs of dehydration such as dizziness, reduced urine output, dark urine, or confusion These features may indicate underlying conditions requiring investigation, such as significant electrolyte disturbances, peripheral neuropathy (particularly relevant in diabetes), peripheral arterial disease, or, rarely, more serious muscle disorders
Currently, a clinical trial comprised of COVID-19 patients evaluating adalimumab, an anti-TNF- drug, has been registered in China (ChiCTR2000030089)
25% off your first order with code WELCOME25 Thirdparty verified, ships same day from the USA BPC-157 + TB-500 BPC-157 + TB-500 is a dual-peptide research formulation studied for coordinated activity within cellular signaling and tissue-matrix pathways
Due to the pure vitamin C (Ascorbic acid) content, there may be discoloration and changes in odor at high temperatures, so please store in a cool, dark place (or refrigerate) after opening